Friday, August 23, 2019 12:15:01 PM
I will make the call on Monday. I could use the last shareholder letter July 2019 as a template for questions. I could ask for a breakdown of where the 45K in revenues came from. I could ask about restocking details for Vitastem at amazon. I will certainly ask about CBD product development.
I did see a pharmacokinetic study of how the trans dermal technology (VDRM)really does mean that more pharmaceutical molecules get delivered through the skin. That study should get published more broadly and replicated by independent academic labs.
I could also ask about the legal status wrt Kasten Corp. and whether another lawsuit would be likely if business for VDRM were to grow substantially.
Thanks
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM
BNCM COMPLETES MERGER WITH DELEX HEALTHCARE • BNCM • Oct 8, 2024 9:54 AM
CBD Life Sciences, Inc. (CBDL) Reaches Unprecedented Heights With Explosive Growth and Strategic Expansion in 2024 • CBDL • Oct 8, 2024 8:00 AM
Unitronix Corp. to Invest $3 Million in USA Unity Coin Project • UTRX • Oct 7, 2024 7:08 AM